For example, in acute myeloid leukemia (AML), two distinct mutations in Smad4 (a missense mutation and a frameshift mutation) disrupt its ability to potentiate TGF-β transcriptional activity [12]. This evidence concerns the gene TGFB1 and acute myeloid leukemia.